Product Description
Atherothrombotic disease is the leading cause of morbidity and mortality; therefore, anti-thrombotic agents play a pivotal role in primary and secondary prevention of atherothrombotic complications. In A Clinical Guide to the Use of Antithrombotic Drugs, three main sections in the field have been elaborated. In the first, 3 chapters on basics concepts of atherothrombosis are examined. The objectives of these chapters are to provide pathophysiological concepts on atherothrombosis useful to the practicing clinician to understand the rationale for using antithrombotic agents in daily practice. In the second section, 16 chapters describe 4 main categories of antithombotic agents used in clinical practice: oral antiplatelet agents, intravenous antiplatelet agents, thrombin inhibitors, and fibrinolytics. In each category, description and clinical application of currently approved agents as well as agents under clinical investigation are described. The objectives of this section are to provide the state of the art knowledge on antithrombotic drug use and development. In the third section, a series of 8 chapters examines the application of antithrombotic agents in specific clinical scenarios. The objective of this section is to provide practical insights on how to apply antithrombotic agents in the context of daily clinical scenarios. Overall, this compendium provides a valuable tool for clinicians in their daily clinical practice on how to use currently available antithrombotic agents as well as provide insights on the future development in this field. ... Read more

Product Description
Yale Univ., New Haven, CT. Provides clinicians with knowledge and the impetus to incorporate preventive strategies into their everyday practices. Includes practical data for the management of patients at risk, but also offers an overview of the new paradigms in the pathophysiology of coronary artery disease. DNLM: Coronary Disease--prevention & control. ... Read more

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on January 15, 2005. The length of the article is 836 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Should men over 40 be screened for coronary artery disease?(Pro & Con)
Author: Daniel S. Berman
Publication: Family Practice News (Magazine/Journal)
Date: January 15, 2005
Publisher: International Medical News Group
Volume: 35Issue: 2Page: 12(1)

Distributed by Thomson Gale ... Read more

Product Description
Diplomarbeit, die am 01.05.1997 erfolgreich an einer Universität in Deutschland eingereicht wurde. Abstract: An ounce of prevention is worth a pound of cure. Rarely are there any objections to this old proverb. Its significance is underscored by the fact that the Major causes of death today are the degenerative, chronic diseases of civilization. Abundant evidence has been accumulated that these diseases can often be prevented. However, the appeal of prevention lies not only in its ability to reduce suffering from disease but also in its assumed power to reduce the costs of health care. At first sight it appears that promoting health and preventing disease would easily rehabilitate the health care system, granting prevention a prominent spot an the health policy agenda. For example in Germany, prevention in the form of health check-ups was introduced to the catalogue of services to be offered by health insurance companies in 1989. Yet, concerns have been raised that prevention may not reduce but rather add to the costs of health care. Especially in the case of prevention of chronic diseases, death or sickness can only be postponed but never avoided. Thus, a careful analysis of all the effects of preventive measures is necessary to assess their full economic consequences. Cardiovascular diseases, primarily coronary artery disease and stroke, account for the majority of deaths in industrialized countries. In the United States these diseases kill nearly as many Americans as all other diseases combined and are also among the leading causes of disability. The aggregate cost of coronary artery disease (CAD) in the United States is enormous, costing the country between 50 and 100 billion dollars per year for medical treatment and lost wages. Nonetheless, over the past two decades, the mortality from cardiovascular disease has declined dramatically: 40 per-cent for coronary artery disease. Major contributions to this decline came from risk factor reduction and c... ... Read more

Product Description
Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Coronary Artery Disease," including when used in literature (e.g. all authors that might have Coronary Artery Disease in their name). As such, this book represents the largest compilation of timeline events associated with Coronary Artery Disease when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social sciences (linguistics, history, geography, economics, sociology, political science), business, computer science, literature, law, medicine, psychology, mathematics, chemistry, physics, biology and other physical sciences. This "data dump" results in a comprehensive set of entries for a bibliographic and/or event-based timeline on the proper name Coronary Artery Disease, since editorial decisions to include or exclude events is purely a linguistic process. The resulting entries are used under license or with permission, used under "fair use" conditions, used in agreement with the original authors, or are in the public domain. ... Read more

Product Description
Univ. of Arkansas, Little Rock. Text on the economic and clinical issues of treating coronary artery disease. For cardiologists. 32 contributors, 29 U.S. DNLM: Coronary Disease--diagnosis. ... Read more

Product Description
CHUV, Lausanne, Switzerland. Provides an anatomical and physiological background as well as a complete review of the alternative methods of revascularization which are under development, namely, transmyocardial laser revasularization, therapeutic angiogenesis, and neurostimulation. ... Read more

Product Description
Pioneers in the field, the authors have assembled an excellent team of contributors to offer their experience on threatened vessel closure and restenosis, acute thrombosis, hyperproliferative cellular response, stents and local drug delivery. ... Read more

Product Description
Pocket-sized handbook includes current information on pathophysiology, diagnostic tests, prevention, drug therapy and other treatments, complications, patient education, and more. For nurses. Includes key concepts, quizzes, memory joggers, and color illustrations of pathophysiology. Trim size: 5.5 x 4.5 inches. Softcover. DNLM: Coronary Disease Handbooks. ... Read more